Intralesional Macular Atrophy in Anti-Vascular Endothelial Growth Factor Therapy for Age-Related Macular Degeneration in the IVAN Trial.

Clare Bailey,Lauren J Scott,Chris A Rogers,Barnaby C Reeves,Barbra Hamill,Tunde Peto,Usha Chakravarthy,Simon P Harding

Ophthalmology（2019）

引用 44|浏览12

暂无评分

摘要

Macular atrophy frequently develops within an nAMD lesion in eyes receiving anti-VEGF therapy over 2 years. No associations between incident MA and drug or treatment frequency or visual function were detected, providing some reassurance to clinicians; however, the longer-term effects remain unknown.

查看译文

关键词

BCVA,CATT,CFP,CI,CNV,CS,FA,FPED,GA,IVAN,MA,nAMD,OR,PED,RPE,SRF,VA,VEGF

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要